Arcadia Biosciences Inc expected to post a loss of 29 cents a share - Earnings Preview

Arcadia Biosciences

12/11/2021 22:32

* Arcadia Biosciences Inc  RKDA.OQ   RKDA.O  is expected to show
a rise in quarterly revenue when it reports  results on November
15. 
* The Davis, California-based company is expected to report  a
698.9% increase in revenue to $2.509 million from $314 thousand
a year ago, according to the mean estimate from 2 analysts,
based on Refinitiv data. 
​* Refinitiv's mean analyst estimate for Arcadia Biosciences Inc
is for a loss of 29 cents per share. For the same quarter last
year, the company reported a loss of 60 cents per share.
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 2 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
* The mean earnings estimate of analysts was unchanged in the
last three months. ​
* Wall Street's median 12-month price target for Arcadia
Biosciences Inc is $5.75​, about 66.8% above​ its last closing
price of $1.91. ​​​
This summary was machine generated November 12 at 22:32 GMT. 
All figures in US dollars  unless otherwise stated